Helicobacter pylori cell envelope and associated virulence machinery (H. pylori cell envelope)

The Helicobacter pylori cell envelope and its associated virulence machinery represent a complex structural and functional apparatus essential for the bacterium's survival in the acidic gastric environment and its pathogenicity (Kusters et al., 2006, Clinical Microbiology Reviews). The envelope consists of an inner membrane, a thin peptidoglycan layer, and an outer membrane containing unique lipopolysaccharides and adhesins like BabA and SabA that facilitate colonization (Doohan et al., 2021, Microorganisms). A critical component of this machinery is the Type IV secretion system (T4SS), encoded by the Cag pathogenicity island, which acts as a molecular syringe to inject the CagA oncoprotein into host gastric epithelial cells (Backert et al., 2015, Cell Communication and Signaling). This interaction triggers inflammatory signaling pathways and cytoskeletal rearrangements, contributing to the development of gastritis, peptic ulcers, and gastric cancer (Amieva and Peek, 2016, Gastroenterology). Therapeutic strategies primarily involve antibiotics like amoxicillin, which targets peptidoglycan synthesis, and bismuth salts that disrupt the cell wall, while modern research focuses on inhibiting specific virulence factors like the T4SS to mitigate disease progression (Malfertheiner et al., 2022, Gut).

Other names

Helicobacter pylori cell wallHelicobacter pylori outer membraneCag pathogenicity islandType IV secretion systemT4SSCagPAIHelicobacter pylori secretome

Inhibition of peptidoglycan cross-linking, disruption of bacterial cell wall integrity, and inhibition of protein or DNA synthesis to compromise the structural and functional integrity of the bacterium (Malfertheiner et al., 2022).